aspirin
FDA Approved
Description
Aspirin is an antiplatelet agent used as adjunctive therapy in Sneddon syndrome to reduce thrombotic risk. It inhibits platelet cyclooxygenase and thromboxane A2 production. Low-dose aspirin is often combined with anticoagulation in patients with antiphospholipid antibodies and cerebrovascular manifestations.
Indications & Therapeutic Use
cardiovascular disease prevention, stroke prevention, Sneddon syndrome, antiphospholipid syndrome
Linked Diseases:
Sneddon syndrome
M30.8D018860
Global Availability (12 countries)
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
aspirin
| Generic Name | aspirin |
| Brands | 1 brand available |
| Active Ingredient | acetylsalicylic acid |
| Drug Class | cardiovascular disease prevention |
| Manufacturer | Bayer |
| Dosage Forms | Oral tablet, 81mg, 325mg |
| Medical Code | B01AC06 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 1 days |
| Reg. Status | FDA Approved |
| Countries | 12 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations13 Validated Nodes